Lixte Biotechnology Inc.

1.33
0.03 (2.31%)
At close: Mar 03, 2025, 3:58 PM
1.21
-9.02%
After-hours: Mar 03, 2025, 03:59 PM EST

Lixte Biotechnology Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05
Cash & Equivalents 4.2M 5.35M 4.82M 5.07M 2.6M 4.27M 1.31M 199.93K 25.28K 44.41K 475.02K 1.66M 14.3K 119.09K 1.54M 10.38K 508.07K 679.64K 4.63K
Short-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a 104.09K 213.7K 6.13K 6.13K 351.13K 1.6M 25K n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets n/a 147.02K 150.24K 76.9K n/a 2.29K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Receivables n/a n/a n/a n/a 14.37K n/a n/a n/a 200K n/a n/a n/a n/a 116.48K n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a n/a n/a 60.92K n/a n/a n/a n/a 44.75K n/a n/a n/a n/a n/a
Other Current Assets 105.13K 207.59K 269.52K 159.21K 93.31K 122.87K 124.63K 233.48K 207.68K 281.19K 33.88K 51.58K 64.34K 94.75K 32.35K 41.14K 120.3K 70.36K n/a
Total Current Assets 4.31M 5.56M 5.09M 5.23M 2.67M 4.33M 1.37M 433.41K 597.98K 539.3K 558.04K 1.75M 429.77K 1.93M 1.6M 51.52K 628.37K 750K 4.63K
Property-Plant & Equipment n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 128.00 742.00 1.06K n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets n/a 147.02K 150.24K 76.9K n/a 2.29K n/a n/a n/a n/a n/a n/a n/a n/a n/a 128.00 742.00 1.06K n/a
Total Assets 4.31M 5.56M 5.09M 5.23M 2.67M 4.34M 1.37M 433.41K 597.98K 539.3K 558.04K 1.75M 429.77K 1.93M 1.6M 51.65K 629.11K 751.07K 4.63K
Account Payables 120.51K 183.75K 225.97K 190.29K 143.55K 195.21K 312.03K 159.59K 159.08K 122.53K 107.77K 80.42K 109.34K 102.34K n/a 92.72K 73.74K 31.79K 14.65K
Deferred Revenue 157.1K 165.02K 76.96K 15.77K 94.35K 15.7K 60.99K 59.06K 124.57K 58.19K 47.28K 14.02K n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 100K n/a n/a n/a
Other Current Liabilities 36.25K 46.98K n/a 10.47K n/a n/a 60.99K n/a 2K 92.72K 214K 180.74K 241.41K 92.72K 300.26K 182.48K 178.44K 92.72K -2.15K
Total Current Liabilities 313.86K 394.79K 302.93K 216.52K 237.9K 210.91K 373.02K 218.65K 285.64K 273.44K 321.77K 261.15K 350.75K 195.06K 300.26K 375.2K 252.18K 124.5K 12.5K
Long-Term Debt n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities n/a 394.79K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Liabilities 313.86K 394.79K 302.93K 216.52K 237.9K 210.91K 373.02K 218.65K 285.64K 273.44K 321.77K 261.15K 350.75K 195.06K 300.26K 375.2K 252.18K 124.5K 12.5K
Total Debt n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 100K n/a n/a n/a
Common Stock 225.00 1.66K 1.37K 1.24K 6.7K 6.7K 5.8K 4.79K 4.79K 4.55K 4.16K 4.16K 3.53K 3.51K 3.05K 2.79K 2.78K 2.66K 270.00
Retained Earnings -48.48M -43.39M -37.08M -30.35M -27.09M -24.65M -22.52M -20.71M -18.57M -15.72M -12.95M -11.58M -8M -5.93M -5.05M -3.5M -2.23M -504.21K -32.87K
Comprehensive Income n/a 0.00 n/a n/a n/a n/a 0.00 0.00 -0.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shareholders Equity 3.99M 5.17M 4.79M 5.01M 2.43M 4.13M 995.04K 214.76K 312.33K 265.86K 236.27K 1.49M 79.02K 1.74M 1.3M -323.55K 376.93K 626.56K -7.87K
Total Investments n/a n/a n/a n/a n/a n/a n/a n/a 104.09K 213.7K 6.13K 6.13K 351.13K 1.6M 25K n/a n/a n/a n/a